- Gastroenterology Advisor

Pancreatic Disorders

FDA Authorizes Marketing of EndoRotor System

Liver

Superior Response Rates, Survival Seen With Personalized Versus Standard Dosimetry Approach in HCC

By

Brandon May

If the current COVID-19 trends persist, the NCI estimates that the pandemic’s impact could threaten the trend of annually decreasing cancer mortality seen in the US since 1990.

General Gastroenterology

Pandemic-Related Delays in Cancer Screenings and Treatment Threaten Progress in Cancer Mortality Rates

By

Tara Haelle

Pancreatic Disorders

Pancreatic Cancer Action Network Launches Adaptive Clinical Trial Platform Aimed at Expediting Drug Development

By

Rachel Narozniak, MA

In this study, a young adult was defined as an individual who was 40 years or younger.

General Gastroenterology

Evolving Incidence Trends in AYA Cancers

By

Andrea S. Blevins Primeau, PhD, MBA

Sometimes the distinctions between cancer treatment groups are a little blurry. Here’s a guide to their definitions and origins.

General Gastroenterology

Targeted Therapies, Immunotherapies, and Immunomodulators: A Quick Guide to Cancer Therapy

By

Katarina Zimmer, MSci, MS

New, less aggressive guidelines have been developed for management of pancreatic cysts.

Pancreatic Disorders

Neoadjuvant Urelumab-Containing Combination Has Preliminary Activity in Pancreatic Cancer

By

Andrea S. Blevins Primeau, PhD, MBA

Pancreatic Disorders

New-Onset Diabetes Identified as Potential Biomarker for Pancreatic Cyst Progression

By

Brandon May

General Gastroenterology

ACG 2020: Siddiqui Spotlights Vital Abstracts

By

Rachel Narozniak, MA

Pancreatic Disorders

HIF1A Activity May Suppress Tumors in Pancreatic Cancer Cells

By

Virginia A. Schad, PharmD, RPh

News

Recent Diabetes,Weight Loss Tied to Pancreatic Cancer Risk

General Gastroenterology

Number of Newly Identified US Patients With Cancer Dropped During COVID-19

Pancreatic Disorders

Utility of Intracystic Glucose for Diagnosis of Mucinous, Non-Mucinous Pancreatic Cysts Examined

By

Emily Pond

Pancreatic Disorders

Zenocutuzumab Gets Orphan Drug Designation for Pancreatic Cancer

By

Brian Park, PharmD

Pancreatic Disorders

Diagnosing and Managing Patients With Primary Pancreatic Lymphoma

By

Roxanne Nelson, RN, BSN

Pancreatic Disorders

Best Practices to Screen for Pancreatic Cancer in High-Risk Individuals

By

Jessica Nye, PhD

News

Platinum Therapy May Up Survival in Pancreatic Cancer With DNA Repair Defects

Pancreatic neoplasms

Clinical, Genetic, Biomarker Model Identifies Risk for Pancreatic Cancer

$Promising results from an earlier-phase study of FOLFOX plus pegilodecakin in metastatic PDAC refractory to gemcitabine provided a rationale for this study.$

Pancreatic Disorders

Addition of Pegilodecakin to FOLFOX Did Not Improve OS in Metastatic Pancreatic Cancer

By

Susan Moench, PhD, PA-C

SN-MMR was strongly associated with OS, melanoma-specific survival, and DFS among patients with a po

Pancreatic Disorders

A Model for Predicting the Risk of Healthy Organ Exposure in Patients With Locally Advanced Pancreatic Cancer Treated With SBRT

By

Susan Moench, PhD, PA-C

Pancreatic Neoplasms

Latest News

FDA Authorizes Marketing of EndoRotor System

Superior Response Rates, Survival Seen With Personalized Versus Standard Dosimetry Approach in HCC

Pandemic-Related Delays in Cancer Screenings and Treatment Threaten Progress in Cancer Mortality Rates

Pancreatic Cancer Action Network Launches Adaptive Clinical Trial Platform Aimed at Expediting Drug Development

Evolving Incidence Trends in AYA Cancers

Targeted Therapies, Immunotherapies, and Immunomodulators: A Quick Guide to Cancer Therapy

Neoadjuvant Urelumab-Containing Combination Has Preliminary Activity in Pancreatic Cancer

New-Onset Diabetes Identified as Potential Biomarker for Pancreatic Cyst Progression

ACG 2020: Siddiqui Spotlights Vital Abstracts

HIF1A Activity May Suppress Tumors in Pancreatic Cancer Cells

Recent Diabetes,Weight Loss Tied to Pancreatic Cancer Risk

Number of Newly Identified US Patients With Cancer Dropped During COVID-19

Utility of Intracystic Glucose for Diagnosis of Mucinous, Non-Mucinous Pancreatic Cysts Examined

Zenocutuzumab Gets Orphan Drug Designation for Pancreatic Cancer

Diagnosing and Managing Patients With Primary Pancreatic Lymphoma

Best Practices to Screen for Pancreatic Cancer in High-Risk Individuals

Platinum Therapy May Up Survival in Pancreatic Cancer With DNA Repair Defects

Clinical, Genetic, Biomarker Model Identifies Risk for Pancreatic Cancer

Addition of Pegilodecakin to FOLFOX Did Not Improve OS in Metastatic Pancreatic Cancer

A Model for Predicting the Risk of Healthy Organ Exposure in Patients With Locally Advanced Pancreatic Cancer Treated With SBRT

Want to read more?

Guidelines for the Diagnosis and Management of Pancreatic Cystic Neoplasms